{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:57:39Z","timestamp":1788548259175,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M733987"],"award-info":[{"award-number":["2023M733987"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300053"],"award-info":[{"award-number":["82300053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["2022-NHLHCRF-LX-01"],"award-info":[{"award-number":["2022-NHLHCRF-LX-01"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijbiomac.2024.133741","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T01:54:56Z","timestamp":1720403696000},"page":"133741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P2","title":["Predictive and therapeutic value of lipoprotein-associated phospholipaseA2 in sarcopenia in chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"275","author":[{"given":"Liwei","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2024.133741_bb0005","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S2213-2600(22)00388-5","article-title":"Moving the pathway goalposts: copd as an immune-mediated inflammatory disease","volume":"10","author":"Cass","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.133741_bb0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-2600(16)00097-7","article-title":"Management of chronic obstructive pulmonary disease beyond the lungs","volume":"4","author":"Vanfleteren","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.133741_bb0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"Copd and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"154","key":"10.1016\/j.ijbiomac.2024.133741_bb0020","article-title":"Sarcopenia in copd: a systematic review and meta-analysis","volume":"28","author":"Benz","year":"2019","journal-title":"European respiratory review\u202f: an official journal of the European Respiratory Society"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.133741_bb0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jamda.2016.05.002","article-title":"Sarcopenia in advanced copd affects cardiometabolic risk reduction by short-term high-intensity pulmonary rehabilitation","volume":"17","author":"Cebron Lipovec","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133741_bb0030","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00628-2021","article-title":"Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with copd and asthma: a population-based study","volume":"8","author":"Benz","year":"2022","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.133741_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041321","article-title":"Impact of body composition and sarcopenia on mortality in chronic obstructive pulmonary disease patients","volume":"12","author":"G\u00f3mez-Mart\u00ednez","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1395170","article-title":"Association of dietary inflammatory indices with sarcopenia and all-cause mortality in copd patients","volume":"11","author":"Jiang","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2018.10.001","article-title":"Psychological co-morbidities in copd: targeting systemic inflammation, a benefit for both?","volume":"842","author":"Pelgrim","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/COPD.S130790","article-title":"Sarcopenia correlates with systemic inflammation in copd","volume":"12","author":"Byun","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"8 Pt 1","key":"10.1016\/j.ijbiomac.2024.133741_bb0055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1164\/ajrccm.164.8.2008109","article-title":"Inflammatory response and body composition in chronic obstructive pulmonary disease","volume":"164","author":"Eid","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.133741_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/crj.13006","article-title":"Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in copd","volume":"13","author":"Formiga","year":"2019","journal-title":"Clin. Respir. J."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133741_bb0065","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase a2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133741_bb0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.plipres.2010.12.001","article-title":"Recent progress in phospholipase a\u2082 research: from cells to animals to humans","volume":"50","author":"Murakami","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133741_bb0075","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbalip.2018.08.009","article-title":"Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases a(2)","volume":"1864","author":"Nikolaou","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133741_bb0080","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.0000280571.28102.d4","article-title":"New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase a2 in atherosclerosis and cardiovascular disease","volume":"27","author":"Tsimikas","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133741_bb0085","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbalip.2018.07.006","article-title":"Platelet-activating factor acetylhydrolases: an overview and update","volume":"1864","author":"Kono","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133741_bb0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.CCM.0000053647.82608.29","article-title":"Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome","volume":"31","author":"Grissom","year":"2003","journal-title":"Crit. Care Med."},{"issue":"5 Pt 1","key":"10.1016\/j.ijbiomac.2024.133741_bb0095","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1164\/ajrccm.158.5.9802036","article-title":"Bronchoalveolar lavage alterations in pulmonary embolism","volume":"158","author":"Nakos","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670971","article-title":"Identification of inflammation-related biomarker lp-pla2 for patients with copd by comprehensive analysis","volume":"12","author":"Deng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0105","article-title":"The emerging roles of paf acetylhydrolase","volume":"50 Suppl(Suppl):S255-9","author":"Mcintyre","year":"2009","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133741_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/med.21597","article-title":"Lipoprotein-associated phospholipase a2: the story continues","volume":"40","author":"Huang","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.133741_bb0115","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","article-title":"Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106286","article-title":"Integrated analysis of single-cell and bulk rna sequencing reveals pro-fibrotic pla2g7(high) macrophages in pulmonary fibrosis","volume":"182","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133741_bb0125","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1038\/s41467-023-41462-9","article-title":"The lipoprotein-associated phospholipase a2 inhibitor darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism","volume":"14","author":"Oh","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0130","article-title":"Ultrasonic elastography of the rectus femoris, a potential tool to predict sarcopenia in patients with chronic obstructive pulmonary disease","volume":"12","author":"Deng","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133741_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12890-021-01663-8","article-title":"Ultrasound assessment of the rectus femoris in patients with chronic obstructive pulmonary disease predicts poor exercise tolerance: an exploratory study","volume":"21","author":"Deng","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/COPD.S234634","article-title":"The protective effect of hbo1 on cigarette smoke extract-induced apoptosis in airway epithelial cells","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fonc.2020.00227","article-title":"Localization of gpsm2 in the nucleus of invasive breast cancer cells indicates a poor prognosis","volume":"10","author":"Deng","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133741_bb0150","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jcsm.13213","article-title":"Glycyl-l-histidyl-l-lysine-cu(2+) rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway","volume":"14","author":"Deng","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115664","article-title":"Oxidative stress: roles in skeletal muscle atrophy","volume":"214","author":"Zhang","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133741_bb0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.2107031","article-title":"Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease","volume":"166","author":"Marquis","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133741_bb0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1183\/09031936.00170111","article-title":"Quadriceps wasting and physical inactivity in patients with copd","volume":"40","author":"Shrikrishna","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133741_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thx.2006.062026","article-title":"Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease","volume":"62","author":"Swallow","year":"2007","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133741_bb0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/biof.1883","article-title":"Platelet activating factor (paf): a mediator of inflammation","volume":"48","author":"Upton","year":"2022","journal-title":"Biofactors"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133741_bb0180","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/biof.1890","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase a(2) (lp-pla(2)) in atherosclerotic cardiovascular disease: an update","volume":"48","author":"Pantazi","year":"2022","journal-title":"Biofactors"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133741_bb0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2217\/bmm-2021-1129","article-title":"Lp-pla2 as a biomarker and its possible associations with SARS-cov-2 infection","volume":"16","author":"Dua","year":"2022","journal-title":"Biomark. Med."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0190","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2147\/NSS.S389253","article-title":"Study on relationship between carotid intima-media thickness and inflammatory factors in obstructive sleep apnea","volume":"14","author":"Ji","year":"2022","journal-title":"Nat Sci Sleep"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133741_bb0195","article-title":"Association of lipoprotein-associated phospholipase a2 with the prevalence of nonalcoholic fatty liver disease: a result from the Apac study","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.133741_bb0200","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0026-0495(99)90240-8","article-title":"Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"48","author":"Khovidhunkit","year":"1999","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133741_bb0205","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the solid-timi 52 randomized clinical trial","volume":"312","author":"O\u2019Donoghue","year":"2014","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.133741_bb0210","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133741_bb0215","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.bmcl.2013.03.062","article-title":"Triazole derivatives: a series of darapladib analogues as orally active lp-pla2 inhibitors","volume":"23","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133741_bb0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trci.2015.06.003","article-title":"A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of alzheimer\u2019s disease","volume":"1","author":"Maher-Edwards","year":"2015","journal-title":"Alzheimers Dement (N Y)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133741_bb0225","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ophtha.2014.12.014","article-title":"Darapladib, a lipoprotein-associated phospholipase a2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study","volume":"122","author":"Staurenghi","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133741_bb0230","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jcsm.12758","article-title":"Association of circulating pla2g7 levels with cancer cachexia and assessment of darapladib as a therapy","volume":"12","author":"Morigny","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133741_bb0235","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/lipd.12191","article-title":"Energy intake and plasma adiponectin as potential determinants of lipoprotein-associated phospholipase a(2) activity: a cross-sectional study","volume":"54","author":"Ntzouvani","year":"2019","journal-title":"Lipids"},{"issue":"6581","key":"10.1016\/j.ijbiomac.2024.133741_bb0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1126\/science.abg7292","article-title":"Caloric restriction in humans reveals immunometabolic regulators of health span","volume":"375","author":"Spadaro","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-511X-8-19","article-title":"Lipoprotein-associated phospholipase a2 (lp-pla2) activity, platelet-activating factor acetylhydrolase (paf-ah) in leukocytes and body composition in healthy adults","volume":"8","author":"Detopoulou","year":"2009","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijbiomac.2024.133741_bb0250","article-title":"Computational investigation of darapladib and rilapladib binding to platelet activating factor receptor. A possible mechanism of their involvement in atherosclerosis","volume":"No.1(6):50-60","author":"Athanasios Papakyriakou","year":"2014","journal-title":"Int. J. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302404546X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302404546X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:37:17Z","timestamp":1782765437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302404546X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"alternative-id":["S014181302404546X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133741","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive and therapeutic value of lipoprotein-associated phospholipaseA2 in sarcopenia in chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133741"}}